Business Pharmaceuticals LeuproRel

Leuprolide acetate is a synthetic nonapeptide analogue of naturally occurring gonadotropin-releasing hormone (GnRH or LH-RH). The analogue possesses greater potency than the natural hormone. It is available in a vial which, when mixed with diluents, become a suspension intended as a monthly intramuscular/ subcutaneous injection.

LeuproRel™ DEPOT developed as a depot preparation of Leuprolide acetate using micro-encapsulated formulation demonstrated continuous release of the drug for 4 weeks and the effective suppression of testosterone after a subcutaneous injection monthly.

LeuproRel™ is indicated in endometriosis and uterine leiomyomata (Fibroids). LeuproRel™ Depot is to be administered subcutaneously/ intramuscularly, varying the injection site periodically, depending on the indication, under the supervision of a physician.

Each composite pack of LeuproRel™DEPOT 3.75 mg contains: One vial of Lyophilized powder of Leuprolide acetate, one ampoule of diluent for reconstitution (2 ml), one sterile syringe, two needles and one alcohol swab. To be reconstituted with diluent.

Scan QR code for pack insert.